) EMBO J. 23, 980-988]. This apoplastic enzyme is a member of the group of "atypical" plant aspartic proteinases. As for other enzymes of this subtype, CDR1 has remained elusive until recently as a result of its unusual properties and localization. Here we report on the heterologous expression and characterization of recombinant CDR1, which displays unique enzymatic properties among plant aspartic proteinases. The highly restricted specificity requirements, insensitivity towards the typical aspartic proteinase inhibitor pepstatin A, an unusually high optimal pH of 6.0-6.5, proteinase activity without irreversible prosegment removal, and dependency of catalytic activity on formation of a homo-dimer are some of the unusual properties observed for recombinant CDR1. These findings unveil a pattern of unprecedented functional complexity for Arabidopsis CDR1 and are consistent with a highly specific and regulated biological function.
INTRODUCTION
Plant aspartic proteinases (APs) are widely distributed in the plant kingdom and have been detected or purified from monocot and dicot species as well as gymnosperms (1) . APs are synthesized as single chain preproenzymes and upon activation converted to mature two-chain enzymes. A characteristic feature of "typical" plant AP precursors is the presence of a protein domain of about 100 amino acids known as the plant specific insert (PSI), which is highly similar to saposin-like proteins and is removed from the precursors upon activation into the mature form of the enzymes (1) . Recently published results on plant APs with unexpected localizations, unusual sequences and novel structural arrangements (2-10) as well as the identification of a wide variety of AP-like proteins in the Arabidopsis genome (11;12) have triggered a redefinition of the classification of plant APs. Faro and Gal have recently proposed a new classification that takes into account the diversity of plant APs by grouping them into typical, nucellin-like and atypical members, with the latter group comprising the majority of the newly identified Arabidopsis APs (11) . Despite having low sequence identity, these atypical and nucellinlike APs share several common features such as 1) the absence of the internal segment PSI in their sequence, 2) an unusually high number of cysteines, 3) the type of amino acids preceding the first catalytic triad, and 4) unexpected localizations, that clearly differentiate them from the well studied typical plant APs. Thus far, only a rather small number of atypical and nucellin-like APs have been studied (2) (3) (4) (5) (6) (7) (8) (9) (10) . However, the proposed roles in highly regulated processes like plastid homeostasis (tobacco CND41) (9;10), disease resistance (Arabidopsis CDR1) (7) or programmed cell death (PCD) (Barley nucellin and Arabidopsis PCS1) (2;8) suggest functional specialization of these particular set of plant APs as found e.g. in mammalian renin as well as tight activity regulation, in contrast to the rather unspecific housekeeping role normally ascribed to typical plant APs. Therefore, there is an increasing interest on the structure and function of atypical and nucellin-like APs. Arabidopsis CDR1 is a member of the larger group of the atypical APs and was first identified by Xia and co-workers while screening for gainof-function mutants displaying enhanced resistance to bacterial pathogens (7) . CDR1 is an extracellular AP and this was the first time a phenotype was associated with the gain-offunction of a gene coding for a plant AP. The enhanced resistance of the CDR1 gain-of-function mutant is likely due to the proteolytic generation of an endogenous peptide elicitor which might be involved in the activation of salicylic-aciddependent local and systemic defence responses. The systemic acquired resistance (SAR) is an inducible plant defence response, conferring longlasting protection against a broad spectrum of microorganisms. Given the controversy on the nature of the systemic signal for SAR (13) (14) (15) , an extensive characterization of CDR1 could give insights into the mechanism by which this atypical AP exerts its function in disease resistance signaling. Here, we report the characterization of recombinant CDR1 overexpressed in E. coli. The recombinant enzyme displays unique enzymatic properties if compared with other plant APs and unprecedented structure-function relationships. The results herein described in combination with the very specific plant phenotype previously reported, strongly support the concept that CDR1 exerts precise, limited and highly regulated proteolytic functions. (forward primer) and 5'-GAGATCACTTCCGGTGGCGGCGATGGCCA TGAT-3' (reverse primer) (mutation underlined). The positive mutant clones were confirmed by DNA sequencing. Both constructs, CDR1 wildtype (wtCDR1) and the mutant CDR1(D108A), were transformed into the E. coli BL21 (DE3) strain. The method of recombinant protein purification was adapted from Castanheira et al (16) . Briefly, after growth of the cells at 37 ºC to D 600 of 0.6, protein expression was induced by the addition of isopropyl thio-β-D-galactoside (0.5 mM final concentration). After 3h, cells were harvested by centrifugation, resuspended in 50 mM Tris/50 mM NaCl (pH 7.4) and lysed with lysozyme (100 µg/ml). After freezing and thawing, DNase (100 µg/ml) and MgCl 2 (100 mM) were added, and the reaction mixture was incubated at 4 ºC for 1 h. The cell lysate was then diluted into 1 L 50 mM Tris/50 mM NaCl (pH 7.4) and washed overnight at 4ºC with agitation. Then, the material was centrifuged at 10000 g and washed again overnight with 50 mM Tris/50 mM NaCl (pH 7.4) containing 0.1 % (v/v) Triton X-100. After centrifugation at 10000 g for 20 min at 4 ºC, the purified inclusion bodies were dissolved in 8 M urea, with 100 mM 2-mercaptoethanol. The protein was refolded by rapid dilution (20-fold) into 20 mM Tris and the pH was slowly adjusted to pH 8.0. The recombinant protein was then concentrated in a tangential flow ultrafiltration system (Pellicon 2, Millipore), ultracentrifuged at 50000 g for 20 min at 4 ºC, and the supernatant applied to an S-300 gel filtration column (Amersham Biosciences) equilibrated in 20 mM Tris/0.4 M urea, pH 8.0 buffer. The protein fractions corresponding to the nonaggregated forms of wild-type or mutant recombinant CDR1 were further purified by ion-exchange chromatography with a High Q (Bio-Rad) column followed by a MonoQ (Amersham Biosciences) column in an FPLC system using the same buffer used for S-300 chromatography. Elution was carried out with a linear gradient of NaCl (0-0.5 M) at a flow rate of 2.0 ml/min or 0.75 ml/min, respectively. Protease activity screening assays -Fluorescein Isothiocarbamoyl Casein (FTC-casein) (Pierce, Rockford, IL, USA) was used as a substrate to measure purified recombinant CDR1 proteolytic activity. Activity was measured according to the manufacturer's protocol. Briefly, a stock solution of FTC-casein was diluted in 25 mM phosphate buffer, 0.15 M NaCl, pH 6.4 and the reaction was started by adding recombinant wtCDR1. The assay mixture was incubated for 5 h at room temperature. Relative fluorescence was measured in a spectrofluorometer and an excitation wavelength of 485 nm and an emission wavelength of 538 nm were used to monitor proteolytic activity. The effect of the selective inhibitor pepstatin was also tested by preincubating the inhibitor for 15 min at 37 ºC with the enzyme before adding the substrate FTCcasein.
EXPERIMENTAL PROCEDURES
The activity towards haemoglobin was tested as follows; a solution of acid-denatured haemoglobin in 0.1 M formate buffer pH 3.0 was incubated with the purified recombinant wtCDR1 for 3h. . After centrifugation (12000 × g, 2 min), the fragments were separated by RP-HPLC in a C18 column, using a Merck Hitachi system with a Hi-Pore RP-318 250 x 4.6 mm column (BioRad). Elution was carried out with a linear gradient (0-80%) of acetonitrile in 0.1 % v/v trifluoroacetic acid for 30 minutes at a flow rate of 1 ml/min. Absorbance was monitored at 220 nm. The isolated peptides were collected, freeze-dried and submitted to automated amino acid sequencing. Enzyme assays -Proteolytic activity of purified recombinant wtCDR1 was tested against several model substrates. Activity assays with the fluorogenic substrates (7-Methoxycoumarin-4-yl)acetyl) (MCA)Lys-Lys-Pro-Ala-Glu-Phe-PheAla-Leu-Lys(DNP) (2,4-Dinitrophenyl) (2 µM) and (MCA)Lys-Ser-Glu-Val-Asn-Leu-Asp-AlaGlu-Phe-Lys(DNP) (2 µM) were performed at different pH values. The following buffers between pH 3 and pH 8 containing 0.1 M NaCl and 8 % (v/v) DMSO were used: 0.05 M sodium citrate pH 3.0; 0.05 M sodium acetate pH 4.0-5.5; 0.05 M sodium phosphate pH 5.5-7.0; 0.05 M Tris-HCl pH 8.0. The enzyme was incubated with each buffer at 37 ºC and the rate of hydrolysis was monitored at an excitation wavelength of 328 nm and an emission wavelength of 393 nm. In the case of the renin substrate tetradecapeptide porcine (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-LeuVal-Tyr-Ser), activity of purified recombinant wtCDR1 was tested by incubation with 0.1 mg of substrate for 5 h at 37ºC and at different pH values. After digestion, the fragments were separated by RP-HPLC in a C18 column, using a Merck Hitachi system with a Hi-Pore RP-318 250 x 4.6 mm column (BioRad) as described in the previous section. Due to the lack of activity towards the model substrates tested, a new peptide substrate was designed for CDR1. The proteolytic activity of purified recombinant wtCDR1 and CDR1(D108A) were then assayed using this synthetic fluorogenic substrate (2 µM) (MCA)Lys-Leu-His-Pro-GluVal-Leu-Phe-Val-Leu-Glu-Lys(DNP) synthesized by Genosphere Biotechnologies (France). The increase of fluorescence intensity produced by substrate hydrolysis was monitored in a spectrofluorometer. An excitation wavelength of 328 nm and an emission wavelength of 393 nm were used to monitor the hydrolysis of this substrate. The relationship between fluorescence change and peptide concentration was determined by measuring the total fluorescence change that occurred upon complete hydrolysis of the peptide with pepsin. For activity studies at different pH, the following buffers between pH 3 and pH 8 containing 0. For activity studies at different temperatures, wtCDR1 was incubated in 0.05 M sodium acetate pH 6.5, 0.1 M NaCl, 8 % (v/v) DMSO buffer at temperatures between 10 ºC and 70 ºC. The same assay conditions were used to assay the activity of the mutant CDR1(D108A) and the fractions collected from size-exclusion chromatography as well as to study the effect of various compounds on the proteolytic activity of recombinant wtCDR1. In this case, the enzyme was preincubated with each compound for 15 min at 37 ºC before determination of proteolytic activity. The kinetic parameters were calculated from the Lineweaver-Burk plot using appropriate software. Size-exclusion chromatography -Native (M r ) of purified recombinant wtCDR1 and CDR1(D108A) was estimated by size-exclusion chromatography on a Superose 12 (Amersham Biosciences) column connected to a FPLC system. The column was equilibrated in 20 mM Hepes pH 7.6, 0.2 M NaCl, 5% glycerol and calibrated with Gel Filtration LMW and HMW calibration kits (Amersham Biosciences) according to the manufacturer's instructions. The MW markers used for calibration were aldolase, 158 kDa; albumin, 67 kDa; ovalbumin, 43 kDa; chymotrypsinogen, 25 kDa; ribonuclease A, 13,7 kDa). Gel electrophoresis -Protein samples were separated by SDS-PAGE using 12% gels in a BioRad Mini Protean III electrophoresis apparatus. Gels were stained with Coomassie Brilliant Blue R-250 (Sigma). Protein samples for chemical Nterminal sequence analysis were separated by SDS-PAGE and subsequently transferred onto polyvinylidene difluoride membranes by electroblotting in 10 mM CAPS, 10 % methanol, pH 11 at 500 mA for 1 h and stained with Coomassie Brilliant Blue R-250. Molecular Modelling -Model building was performed on a structure of Mucor pusillus aspartic proteinase (PDB-code: 1mpp). A sequence alignment of CDR1 deduced amino acid sequence (accession number AY243479) and Mucor pusillus aspartic proteinase (sequence from PDB-file) yielded sequence identity of 22%. Modelling calculations were done on a SGI Octane workstation with dual R12000 processors using the program Moloc (17) (www.moloc.ch). An initial C-alpha model of CDR1 was built by fitting its aligned sequence on the Mucor pusillus template C-alpha structure followed by optimization of newly introduced loops. A number of new disulphide bridges were introduced between adjacent Cys in the structure. Subsequently a full atom model was generated and newly inserted loops were optimized with the rest of the protein kept stationary. Refinement of the full model with manual removal of repulsive vdW interactions followed and was divided in three parts. First only amino acid side chains were allowed to move, in a second step all atoms except alpha carbons were optimized and finally, positional constraints were put on alpha carbons only. Quality checks were made with Moloc internal programs and with a program by Luthy et al (18) .
RESULTS

Expression, refolding and purification of recombinant CDR1 -
The atypical AP CDR1 (Fig.1) was first identified by T-DNA activation tagging and it was shown that its function in the activation of inducible resistance mechanisms required protease activity (7) . To characterize the structural and enzymatic properties of this plant AP we have cloned its full-length cDNA (nucleotide sequence available in the EBI Data Bank under the accession number AY243479) from Arabidopsis seedlings.
An expression plasmid construct was subsequently generated containing the cDNA encoding CDR1 without the first 25 amino acid residues which were assumed to correspond to the putative signal peptide (predicted by SignalP (19) ). The CDR1-pET-23d (wtCDR1) construct was expressed in E. coli BL21 (DE3) strain and resulted in accumulation of the protein in inclusion bodies. They were purified by a freeze/thaw and detergent washing procedure and subsequently dissolved in urea. Protein refolding was induced by a rapid dilution step followed by pH adjustment. After refolding the protein was purified by size exclusion chromatography on a Sephacryl S-300 column and the protein fractions corresponding to the non-aggregated forms of the enzyme were further purified by ion-exchange chromatography with a High Q and Mono Q columns. SDS-PAGE analysis of the purified protein fractions confirmed the presence of a protein with an apparent molecular mass of 50 kDa (Fig. 2) . Since the predicted mass of the nonglycosylated form of wtCDR1 is 45 kDa, the identity of the purified protein was subsequently determined by Edman degradation. The results on N-terminal sequencing of the electroblotted purified protein confirmed the expected Nterminal sequence of wtCDR1 (underlined) -ASKPKLG -with AS being encoded by the pET23d sequence.
Proteolytic activity of recombinant wtCDR1 -Despite a relatively low amino acid sequence identity with typical plant APs, the CDR1 sequence contains the typical hallmarks of aspartic proteinases. This includes the active site consensus sequence motifs (DTG/DSG) and the two hydrophobic-hydrophobic-Gly motifs of the Psi-loops. Moreover, the fact that the active-site mutant failed to recapitulate the CDR1-D-like phenotype (7) further support the assignment of CDR1 as an aspartic protease with novel features.
The purified recombinant wtCDR1 was tested for proteolytic activity against several model substrates (Table I) . The synthetic fluorogenic substrate (MCA)Lys-Lys-Pro-Ala-Glu-Phe-PheAla-Leu-Lys(DNP), whose chromogenic version with a p-nitrophenylalanine group in the P1 position (20) has been successfully hydrolyzed by a wide variety of aspartic proteinases from animal, microbial or plant origins, was not cleaved by recombinant wtCDR1 and therefore no activity was observed at a pH range from 3 to 8. This result provided a first evidence that wtCDR1 prefers different substrates from those cleaved by plant APs studied thus far. Moreover, neither the fluorogenic BACE1 substrate (MCA)Lys-SerGlu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DNP) (21) nor the known renin substrate Asp-Arg-ValTyr-Ile-His-Pro-Phe-His-Leu-leu-Val-Tyr-Ser (Sigma-Aldrich) were cleaved by wtCDR1 in any of our activity assays. When haemoglobin, BSA or FTC-casein were probed as substrates, wtCDR1 processed only the latter. In fact, purified recombinant wtCDR1 displayed a narrow pH-tolerance for this substrate with a pH optimum at 6.4. Moreover, pepstatin A -a widely used inhibitor of aspartic proteinases -inhibited this FTC-casein processing very weakly (data not shown). This narrow substrate specificity together with the observed low sensitivity towards pepstatin A and an unusually high optimal pH prompted us to further investigate the catalytic properties of CDR1. Rather unexpectedly, and in contrast to other aspartic proteinases, wtCDR1 cleaved the Leu15-Phe16 bond of the insulin B chain in a selective manner at an optimal pH of 6.0. Under these conditions, addition of pepstatin A only partially inhibited this cleavage activity.
Design of a new fluorogenic substrate for CDR1
characterization -Due to the unusual specificity requirements displayed by wtCDR1 a new substrate was required. Therefore, a 3D-model of CDR1 was generated (for details see Experimental Procedures). Scrutinizing the active site yielded no surprises revealing mostly hydrophobic residues forming binding pockets S2' to S3. However, two rather interesting features are reminiscent of human BACE (22) . These are the short proline rich loop and Arg400 (Fig. 3) which reaches into the active site and might be capable of forming a salt bridge with a negatively charged glutamate residue in S4. A striking feature of wtCDR1 is its rather high pH optimum of 6.25-6.5 that is even higher than the value (5.0) found for human BACE (23) . At such a pH a glutamate should be deprotonated even at the interface between bulk water and protein interior. Considering size, shape and physicochemical properties of the individual active site subpockets in modeled CDR1 we have designed a new peptide substrate, (MCA)LysLeu-His-Pro-Glu-Val-Leu-Phe-Val-Leu-GluLys(DNP), which turned out to be efficiently cleaved by recombinant wtCDR1 and was subsequently used for enzyme characterization. The ionizable residues at each end of the peptide were introduced for solubility reasons. Mass spectrometry analysis of the peptide digestion products yielded a major fragment (m/z 1220.60) which originates from the sequence (MCA)LysLeu-His-Pro-Glu-Val-Leu-Phe, therefore suggesting that the peptide is cleaved at the PheVal bond. The pH and temperature dependence of the recombinant enzyme are shown in Fig. 4 and some obvious differences between recombinant wtCDR1 and the majority of the typical plant APs were striking. Recombinant wtCDR1 is optimally active in the pH range 6.25 -6.5 and retains 50 % activity at pH 5.75-6.0. However, no proteolytic activity was detected when assays were performed at pH values lower than pH 5.0 (Fig. 4A) . The activity of the purified enzyme was optimal at 37ºC, decreasing abruptly at temperatures higher than 40ºC with no activity above 60ºC (Fig. 4B) . This high pH optimum observed for wtCDR1 is reminiscent of human renin (pH opt 6.0) which also acts in the extracellular space when cleaving its substrate, angiotensinogen (24) . The effect of several class-specific inhibitors on recombinant wtCDR1 activity was also studied and is summarized in Table II . None of the usually class-specific inhibitors could completely inhibit the enzyme activity. Pepstatin A, a widely active aspartic protease inhibitor, only partially inhibited this activity (52.6 % at 0.001 mM). This supports the hypothesis that CDR1 requires special features such as a negative charged glutamate (pH 6.0) in the S4 site for tight binding. Rather surprisingly pefabloc, a serine protease inhibitor, also had a partial inhibitory effect on CDR1 activity. To our knowledge, this has not previously been observed for any plant AP. Neither E-64, a cystein protease inhibitor, nor amastatin, an aminopeptidase inhibitor showed any detectable inhibition against wtCDR1. The partial inhibition observed for the chelating agent EDTA suggests that a metal ion might be important for enzyme activity, most likely as part of a structural motif. The effects of redox reagents and nucleotides were also examined. While protease activity was strongly inhibited by ATP, NADPH only had a partial inhibitory effect. Reduced (GSH) and oxidized (GSSG) glutathione had a more pronounced inhibitory effect than DTT, with GSSG completely inhibiting wtCDR1 activity. These experimental evidences strongly support the hypothesis that (unpaired) CDR1 cysteine residues play a crucial role for enzyme activity. In order to exclude the presence of a contaminating protease from E. coli and due to the unusually optimal pH detected, an active site D108A mutant of CDR1 (see Fig. 1 ) was generated and expressed in E. coli. However, no activity was detected for this mutant in a standard assay using our newly designed substrate peptide (Fig. 5) . This result corroborated our hypothesis that CDR1 is indeed an active aspartic proteinase. Recombinant wtCDR1 showed typical MichaelisMenten kinetics with the fluorogenic peptide (MCA)Lys-Leu-His-Pro-Glu-Val-Leu-Phe-ValLeu-Glu-Lys(DNP) (data not shown) and the K m and apparent k cat parameters determined for the hydrolysis of this substrate were 0.75 µM and 6.4 × 10 -3 s -1
, respectively.
Recombinant CDR1 is more active as a dimerArabidopsis CDR1, like most APs of the group of atypical plant A1 family members, is characterized by an unusually high number of cysteine residues (13 residues for CDR1 -one in the putative signal peptide -compared to 6 Cys residues found in the mature form of typical plant APs). This intriguing sequence feature, together with our experimental evidences on the pronounced inhibitory effect of redox reagents (see Table II ) indicate that CDR1 cysteine residues may play a crucial role in enzyme stability and activity. In a first step, recombinant wtCDR1 active fraction was analyzed in SDS-PAGE under reducing and non-reducing conditions. As shown in Fig. 6 , the migration pattern of wtCDR1 in the absence of β-mercaptoethanol clearly suggested the presence of entities with different oligomerization state of CDR1. Subsequently, we subjected active enzyme fraction to size-exclusion chromatography and obtained two separated peaks (Fig. 7A) . Three different fractions (named 1, 2 and 3) were collected and analyzed by SDS-PAGE under reducing and non-reducing conditions respectively. As shown in Fig. 7B , each of the collected fractions comprised different oligomeric forms of recombinant wtCDR1 when run in the absence of the reducing agent. In fact, based on the calibration of the size-exclusion chromatography column with molecular weight standards, the estimated molecular weight of fraction 2 was ~98 kDa whereas fraction 3 migrated at ~48 kDa. Hence, and as confirmed by SDS-PAGE (Fig. 7B) , fraction 2 and fraction 3 likely correspond to CDR1 dimers and monomers, respectively, whereas fraction 1 mostly comprised CDR1 oligomers larger than 200 kDa. All three fractions were assayed with the fluorogenic substrate (MCA)Lys-Leu-His-ProGlu-Val-Leu-Phe-Val-Leu-Glu-Lys(DNP). Fraction 2 comprising mostly CDR1 dimers was highly active in contrary to the other fractions comprising either higher aggregates (fraction 1) or CDR1 monomers (fraction 3) (Fig. 7C) , thereby suggesting that a dimerized state is optimal for CDR1 proteolytic activity.
DISCUSSION
A large number of AP-like proteins have been identified in silico in the Arabidopsis thaliana genome (11) . So far only a few of them have actually been isolated and characterized, raising the possibilities that these proteinases may have remained elusive as a result of atypical enzymatic properties, short life time or unexpected localizations. We have successfully cloned, expressed and purified Arabidopsis CDR1 and our results indicate that this enzyme displays properties that are significantly different from those of the well-studied typical plant APs. While recombinant CDR1 performs proteolytic cleavages at a higher pH compared to most APs, we clearly demonstrated the correct assignment to the family of APs by inactivating the enzyme through modification of an aspartate residue in the consensus DTG motif that is crucially required for proteolytic activity. The dependence of enzymatic activity on this single aspartate indicates that CDR1 is an active aspartic proteinase. Our results on the characterization of recombinant CDR1 showed that this enzyme has a multitude of properties clearly differing from those of typical plant APs. In fact, highly restricted specificity requirements, insensitivity towards the archetypical aspartic proteinase inhibitor pepstatin A, unusually high optimal pH 6.0-6.5 proteinase activity without irreversible removal of the prosegment and last but not least formation of a homo-dimer required for optimal catalytic activity are some of the unusual properties observed for recombinant CDR1 that distinguishes it from the typical plant APs. Even though there are examples of aspartic protease displaying at least one of the above mentioned properties: CND41 is well known for its insensitivity to pepstatin (3), renin and the HIV-proteinase are both optimally active at pH around 6.0 (25;26), BACE and renin show significant protease activity without irreversible removal of their prosegment (27;28) and cathepsin E is active as a homodimer (29;30), CDR1 is unique in displaying all these features. This reflects a pattern of unprecedented functional complexity and is consistent with a specific biological function. Its proposed role as a generator of a peptide elicitor in a highly regulated process such as pathogen disease resistance signaling suggests that CDR1 may be involved in highly specific proteolytic events requiring sequence specificity and tight activity regulation. According to our results, recombinant CDR1 does not cleave substrates commonly processed by typical plant APs. The narrow substrate specificity apparently requiring a glutamate in the S4 pocket is consistent with a tightly regulated and highly specific conversion of a unique substrate. A negative charged Glu is also very crucial for effective conversion of BACE substrates (31;32). The cleavage site between a phenylalanine and a valine as found in our newly designed substrate is quite common for APs. It is most likely the negative ionizable Glu in S4 that provides the exclusive specificity determined in our assays. Moreover, the clear shift towards higher pH values indicated an unusual enzyme localization and is in agreement with an extracellular localization (7) of CDR1, strengthening the idea that this enzyme might be functionally active in vivo. The inhibitory effect of redox reagents observed for recombinant CDR1 suggested a new mechanism of regulation of proteolytic activity either by influencing the monomer vs. dimer ratio or by affecting structurally important intramolecular disulfide bonds. Unlike typical plant APs, which comprise only three well conserved intramolecular disulphide bridges in their mature form, CDR1 is characterized by the presence of twelve cysteine residues. We demonstrated that CDR1 is most active as a dimer and that dimerization is probably stabilized via intermolecular disulphide bridges. Our model of CDR1 foresees no obvious partners for intramolecular disulfide bond formation for Cys 358 and Cys 396 leaving them as prime candidates for intermolecular disulfide bond formation despite their slightly concealed location. This disulfide bridge mediated homodimerization reminds of human cathepsin E since this enzyme, to the best of our knowledge, is the only A1 AP that exists as a disulfide bridged homodimer (29;30) . However, while cathepsin E monomers are fully catalytically active and the disulfide bond appears to increase mostly the enzyme stability, for CDR1 homodimer formation is critical for full proteolytic activity. Redox dependent regulation of protein function is emerging as a fundamental aspect in disease resistance signaling with recent findings implicating changes in the cellular redox status as a driving force underlying SAR (13;33-35) . Our results provide strong evidence that CDR1's proteolytic activity may be regulated via a disulfide mediated monomer/dimer equilibrium. Further support for this hypothesis is the apoplastic localization of CDR1 (7) . It is currently accepted that the low antioxidant buffering of the apoplast may heighten or facilitate redox signaling (35) and therefore it appears conceivable that the oxidative signals generated in response to biotic stresses may have an effect on the monomer/dimer ratio of CDR1. This redoxdependent activation proposed for CDR1 may constitute an additional fine-tuned regulation mechanism underlying plant defence responses. Nevertheless, further studies are required to elucidate if and how the redox state of CDR1 cysteines regulate protein function in vivo. The existence of a putative zinc binding site in CDR1 is also suggested from our experimental evidence, however we cannot completely exclude unspecific binding of zinc to our enzyme. The role of zinc in a number of microbial, animal or plant proteins is well-established (36) (37) (38) . However, in the particular case of aspartic proteinases, only the non-functional atypical AP-like protein Bla g 2 (39), isolated from cockroach, and tobacco CND41 (6) were described with zinc binding sites. The potential structural and/or regulatory role of a putative zinc binding site in CDR1 remains to be established. Taken together, the findings herein described show that recombinant CDR1 displays highly unusual enzymatic properties and unveil a pattern of rarely found functional complexity. Determination of its three-dimensional structure and identification of its natural substrate will be necessary to better understand the functional role of this enzyme in response to stress injuries. .
The abbreviations used are: AP, aspartic proteinase; PSI, plant-specific insert; CDR1, constitutive disease resistance 1; PCS1, promotion of cell survival 1; CND41, chloroplast nucleoid DNA-binding protein; SAR, systemic acquired resistance; E-64, L-trans-epoxysuccinyl-leucylamide-(4-guanidino)-butane; DMSO, dimethyl sulfoxide; CAPS, 3-(cyclohexylamino)propanesulfonic acid; PVDF, polyvinylidene fluoride membrane; HPLC, high pressure liquid chromatography; GSH, glutathione reduced; GSSG, glutathione oxidized; ATP, adenosine 5'-triphosphate; DTT, DL-dithiothreitol; BSA, bovine serum albumin; NADPH, β-nicotinamide adenine dinucleotide 2′-phosphate reduced; ; EDTA, Ethylenediaminetetraacetic acid; FIGURE LEGENDS: Figure 1 . Deduced amino acid sequence of Arabidopsis thaliana CDR1. Distinguishing sequence features of the atypical group of plant APs where CDR1 is included are highlighted in the sequence and comprise: 1) two putative catalytic sequence motifs (shown in bold) with the first catalytic triad characterized by the amino acid sequence hydrophobic-hydrophobic-DTG-serine-acidic; 2) a high content in cysteine residues (shown in bold in the grey boxes) and 3) a cysteine residue at the C-terminus of the protease domain. In opposition to typical plant APs, these atypical enzymes have no PSI. However, they are characterized by the presence of a specific insertion of a cysteine rich domain between the first catalytic sequence and the flap tyrosine residue (double underlined) whose specific role is still undefined. Underlined sequence corresponds to the putative signal peptide (predicted by SignalP) that was absent in the expression construct used in this work. The active-site aspartic acid residue marked with an asterisk was mutated to an alanine residue to generate the active site mutant CDR1(D108A). Proteolytic activity of purified recombinant wtCDR1 was tested against several model substrates. The assays were performed as described in the experimental procedures. No activity was observed for the majority of peptides or protein substrates used (n.c.: not cleaved). The exceptions were oxidized insulin B chain (cleaved at Leu15-Tyr16) and FTC-casein.
TABLE II
Proteolytic activity inhibition profile of recombinant wtCDR1 Recombinant wtCDR1 was tested for activity using the synthetic fluorogenic peptide (MCA)Lys-LeuHis-Pro-Glu-Val-Leu-Phe-Val-Leu-Glu-Lys(DNP) as substrate in 0.05 M sodium acetate pH 6.5, 0.1 M NaCl, 8 % (v/v) DMSO buffer at 37 ºC. The enzyme was preincubated in the presence of each compound for 15 minutes at 37ºC before adding the substrate. 
